Research Article

Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children

Table 3

Relationship between hepatic fibrosis markers, IHF, and biochemical parameters.

CIVLNLN HALN PCIIILN IHFNFSLN APRILN FIB-4

Age−0.011−0.0120.011−0.0220.1640.2880.126 0.525
WC0.055−0.0890.0590.0560.326−0.022 0.166−0.111
SBP0.024−0.09−0.020.0550.1470.1890.122 0.207
Uric acid0.135−0.0660.1060.1630.4140.2130.2590.173
HDL−0.214−0.067−0.201−0.049−0.296−0.134 −0.276−0.109
LDL−0.013−0.0460.0460.0420.1700.1240.1360.042
LN TG−0.0060.0470.0910.1220.2740.0920.112−0.075
LN ALT0.2240.0150.1450.2330.7250.040 0.7800.156
LN AST0.3150.1070.1380.3120.5450.059 0.8880.398
LN γ-GT0.195−0.0010.1630.2460.5860.0590.6320.201
LN F insulin−0.068−0.0780.0980.0420.1640.145−0.104−0.083
LN insulin 120−0.04−0.089−0.198−0.080.0910.033−0.0220.017
Fasting glucose0.0650.1900.1760.031−0.0130.3760.104 0.097
LN OGTT 1200.0420.090.1310.0350.2470.1840.207 0.107
HbA1c−0.0410.207−0.0550.1900.117−0.0010.0940.121
LN HOMA-IR−0.057−0.050.1230.0450.1630.198−0.083−0.065
MS score0.1460.1710.1720.0630.2300.3580.234 0.165

Pearson’s correlation tests were performed. The variables without normal distribution were natural base logarithmic (LN) transformed to normal distribution before analysis. ; .